Press Release: Casma : Casma Therapeutics to Present at 2021 Stifel Virtual Healthcare Conference
CAMBRIDGE, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Casma Therapeutics, Inc., a biotechnology company harnessing the power of autophagy to design innovative new medicines, today announced that Chief Executive Officer, Keith Dionne, Ph.D., will present at the upcoming Stifel Virtual Healthcare Conference on Wednesday, November 17, 2021 at 10 a.m. ET.
Read full article »
Casma is a Massachusetts-based biotechnology company that develops therapies for the treatment of cancer, inflammation, neurodegeneration, and metabolic disorders.
Read more